Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 6—June 2009

Dispatch

Vancomycin-Resistant Staphylococcus aureus, Michigan, USA, 2007

Jennie FinksComments to Author , Eden Wells, Teri Lee Dyke, Nasir Husain, Linda Plizga, Renuka Heddurshetti, Melinda Wilkins, James Rudrik, Jeffrey Hageman, Jean Patel, and Corinne Miller
Author affiliations: Michigan Department of Community Health, Lansing, Michigan, USA (J. Finks, E. Wells, T.L. Dyke, M. Wilkins, J. Rudrik, C. Miller); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Finks, J. Hageman, J. Patel); St. John Macomb-Oakland Hospital, Warren, Michigan, USA (N. Husain, L. Plizga); William Beaumont-Troy Hospital, Troy, Michigan, USA (R. Heddurshetti)

Main Article

Figure 1

Vancomycin-resistant Staphylococcus aureus (VRSA) culture, treatment, and period of potential transmissibility timelines, 2 patients, February 2007–April 2008. Top, patient 1; bottom, patient 2; pos, positive; neg, negative.

Figure 1. Vancomycin-resistant Staphylococcus aureus (VRSA) culture, treatment, and period of potential transmissibility timelines, 2 patients, February 2007–April 2008. Top, patient 1; bottom, patient 2; pos, positive; neg, negative.

Main Article

TOP